Skip to main content

Global Biopreservation Market predicted to grow at 15% CAGR as regenerative medicine adoption 2030

 


The biopreservation market is anticipated to grow at a CAGR of 15% during the forecast period. This growth is largely driven by the increasing demand for personalized medicine and cell-based therapies, rising number of biobanks and tissue banks, and growing R&D investments in life sciences and biotechnology. However, the high cost of these advanced equipment and the need for strict regulatory compliance, may hinder the market growth. 

Biopreservation refers to the method of preserving biological samples such as cells, tissues, blood, and organ. This method typically involves the use of cryogenic temperatures and chemical agents called cryoprotectants that prevent ice crystal formation, which may damage the cell structures. The technique ensures that the biological samples retain their structural and functional integrity during storage and after thawing. Biopreservation plays a significant role in biobanking, regenerative medicine, and the long-term storage of biospecimens for research and clinical trials.

Discover the more details-Download the PDF brochure:
https://meditechinsights.com/biopreservation-market/request-sample/

Stem cell therapies amplify need for advanced biopreservation solutions

The primary factor driving the biopreservation market is the rising demand for regenerative medicine, along with the growing demand for the therapies including stem cell therapy, gene editing, and tissue engineering which rely on the ability to store biological samples in a way that maintains their integrity over time. Biopreservation helps ensure that stem cells and tissues remain viable and effective, even after extended periods in storage. The growing adoption of stem cell for treating chronic conditions like diabetes, CVD, and Parkinson’s disease and the rising number of clinical trials associated with these therapies, underscores the need for advanced storage solutions.  Additionally, healthcare institutions and biotech firms are investing in improved cold chain systems and standardized biobanking protocols to ensure sample quality and traceability. For instance, in April 2024, Thermo Fisher Scientific has introduced its new ENERGY STAR certified TSX Universal Series ultra-low temperature (ULT) freezers, designed to deliver better temperature control, faster recovery times, and enhanced energy efficiency, while supporting diverse laboratory workflows and sustainability goals

Improved post-thaw viability fuels vitrification adoption across applications

The biopreservation landscape is experiencing a noticeable evolution, shaped by a series of transformative trends. The growing preference for vitrification, a rapid freezing method that transforms biological sample into glass-like, solid states avoids ice crystal formation along with the development of safer, more efficient cryoprotectant formulations, which enhance sample viability. This method utilizes high concentrations of cryoprotectants combined with ultra-rapid cooling to prevent crystallization. This technique has been proved beneficial for sensitive cells like female egg cell, stem cell or embryos whose cell membrane can rupture in traditional slow freezing methods. Since this method has improved post-thaw survival rates and functionality, there is seen growing adoption of it in organ transplantation, regeneration research, and fertility preservation. Its success in minimizing structural damage during freezing and thawing has expanded its adoption in both clinical and research settings. Vitrification not only improves storage outcomes but also aligns with the growing need for precise, reproducible biopreservation methods as the scope of biomedical applications continues to grow.

Competitive Landscape Analysis

The global biopreservation market is marked by the presence of established and emerging market players such as Azenta US, Inc.; Biomatrica, Inc. (Exact Sciences Corporation); BioLife Solutions; MVE Biological Solutions; Taylor-Wharton; Thermo Fisher Scientific, Inc.; LabVantage Solutions, Inc; X-Therma Inc.; PrincetonCryo.; Panasonic Healthcare Holdings, Co., Ltd; and Stirling Ultracold among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/biopreservation-market/request-sample/

Global Biopreservation Market Segmentation

This report by Medi-Tech Insights provides the size of the global biopreservation market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, biospecimen, application, and end-user.

Market Size & Forecast (2023-2030), By Product, USD Million

  • Equipment
    • Freezers
    • Refrigerators
    • Cryogenic Storage
    • Others
  • Media
    • Cryopreservation
    • Hypothermic Preservation
  • Lab Information Management System

Market Size & Forecast (2023-2030), By Biospecimen, USD Million

  • Tissue
  • Organs
  • Stem cells
  • Others

Market Size & Forecast (2023-2030), By Application, USD Million

  • Therapeutics
  • Research

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Biobanks
  • Hospitals
  • Gene Banks
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more